What is benzgalantamine (Zunveyl®) and how is it different?

This article was published and approved by experts on August 13, 2024. Additional text about the conversion of benzgalantamine to galantamine was added on August 14, 2024. In 2024, the US Food and Drug Administration (FDA) approved benzgalantamine delayed-release tablets (Zunveyl®), a cholinesterase inhibitor with an FDA indication “for the treatment of mild to moderate…